메타분석 = Meta-analysis

참고문헌 (Reference)

1 Williams RL, "Use of antibiotics in preventing recurrent acute otitis media and in treating otitis media with effusion: a meta-analytic attempt to resolve the brouhaha" 270 : 1344-1351, 1993

2 Fleiss JL, "The statistical basis of meta-analysis" 2 : 121-145, 1993

3 Rosen CJ, "The rosiglitazone story - Lessons from an FDA advisory committee meeting" 357 : 844-846, 2007

4 Psaty BM, "The record on rosiglitazone and the risk of myocardial infarction" 357 : 67-69, 2007

5 Juni P, "The hazards of scoring the quality of clinical trials for meta-analysis" 282 : 1054-1060, 1999

6 Cochran WG, "The combination of estimates from different experiments" 10 : 101-129, 1954

7 Cook DJ, "Systematic reviews: synthesis of best evidence for clinical decisions" 126 : 376-380, 1997

8 Egger M, "Systematic reviews in health care: Meta-analysis in context" BMJ Publishing Group 2001

9 Higgins JPT, "Statistical heterogeneity in systematic reviews of clinical trials: a critical appraisal of guidelines and practice" 7 : 51-61, 2002

10 Hedges LV, "Statistical Methodology in Meta-Analysis" Educational Testing Service 1982

11 Meade MO, "Selecting and appraising studies for a systematic review" 127 : 531-537, 1997

12 The RECORD study group, "Rosiglitazone evaluated for cardiovascular outcomes-an interim analysis" 357 : 28-38, 2007

13 Letters to the editor, "Rosiglitazone and the FDA" 357 : 1775-1777, 2007

14 Psaty BM, "Rosiglitazone and cardiovascular risk" 356 : 2522-2524, 2007

15 Nathan DM, "Rosiglitazone and cardiotoxicity-weighing the evidence" 357 : 64-66, 2007

16 Drazen JM, "Rosiglitazone -continued uncertainty about safety" 357 : 63-64, 2007

17 Pearson K, "Report on certain enteric fever inoculation statistics" 3 : 1243-1246, 1904

18 Song F, "Publication and related biases" 2004 : 1-105,

19 Glass GV, "Primary, secondary and meta-analysis of research" 5 : 3-8, 1976

20 Stewart LA, "Practical methodology of meta-analysis (overviews) using updated individual patient data" 14 : 2057-2079, 1995

21 Greenhalgh T, "Papers that summarise other papers (systematic reviews and meta-analyses)" 315 : 672-675, 1997

22 Chalmers I, "Non-random reflections on health services research" BMJ Publishing Group 1997

23 Sutton AJ, "Methods for meta-analysis in medical research" John Wiley and Sons 2000

24 Davey Smith G, "Meta-analysis: unresolved issues and future developments" 316 : 221-225, 1998

25 Egger M, "Meta-analysis: principles and procedures" 315 : 1533-1537, 1997

26 Egger M, "Meta-analysis: potentials and premise" 315 : 1371-1374, 1997

27 Shapiro S, "Meta-analysis/Shmeta-analysis" 140 : 771-778, 1994

28 The MOOSE group, "Meta-analysis of observational studies in epidemiology. a proposal for reporting" 283 : 2008-2012, 2000

29 Rosenfeld RM, "Meta-analysis of antibiotics for the treatment of otitis media with effusion" 106 : 378-386, 1992

30 DerSimonian R, "Meta-analysis in clinical trials" 177 : 177-186, 1986

31 L’Abbe KA, "Meta-analysis in clinical research" 107 : 224-233, 1987

32 Lee JY, "Medical Statistics at a Glance" Epublic 2007

33 Higgins JPT, "Measuring inconsistency in meta-analyses" 327 : 557-560, 2003

34 "Letters to the editor: Rosiglitazone and cardiovascular risk" 357 : 930-940, 2007

35 Furberg CT, "Lessons from overviews of cardiovascular trials" 6 : 295-303, 1987

36 Greenland S, "Invited commentary: a critical look at some popular meta-analytic methods" 140 : 290-296, 1994

37 Glasziou PP, "Investigating causes of heterogeneity in systematic reviews" 21 : 1503-1511, 2002

38 The ADVANCE collaborative group, "Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes" 358 : 2560-2572, 2008

39 The QUOROM group, "Improving the quality of reports of meta-analyses of randomized controlled trials: the QUOROM statement" 354 : 1896-1900, 1999

40 Jadad AR, "Gavaghan, DJ, McQuay H: Assessing the quality of reports of randomized clinical trials: Is blinding necessary?" 17 : 1-12, 1996

41 Counseil C, "Formulating questions and locating primary studies for inclusion in systematic reviews" 127 : 380-387, 1997

42 Schmid CH, "Exploring heterogeneity in randomized trials via meta-analysis" 33 : 211-224, 1999

43 Song F, "Exploring heterogeneity in meta-analysis: is the L’Abbe plot useful?" 52 : 725-730, 1999

44 Sackett DL, "Evidence-based medicine: what is it and what it isn’t" 312 : 71-72, 1996

45 Sackett DL, "Evidence-based medicine: how to practice and teach EBM. 2nd ed" Churchill -Livingston 2000

46 Schulz KF, "Empirical evidence of bias: Dimensions of methodological quality associated with estimates of treatment effects in controlled trials" 273 : 408-412, 1995

47 Kerlikowske K, "Efficacy of screening mammography: a meta-analysis" 273 : 149-154, 1995

48 The ACCORD study group, "Effects of intensive glucose lowering in type 2 diabetes" 358 : 2545-2559, 2008

49 Cochrane AL, "Effectiveness and efficiency: Random reflections on the health service" Nuffield Provincial Hospitals Trust 1972

50 Nissen SE, "Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes" 356 : 2457-2471, 2007

51 Moher D, "Does quality of reports of randomized trials affect estimates of intervention efficacy reported in meta-analyses?" 352 : 609-613, 1998

52 LeLorier J, "Discrepancies between meta-analyses and subsequent large randomized, controlled trials" 337 : 536-542, 1997

53 Thompson SG, "Controversies in meta-analysis: the case of the trials of serum cholesterol reduction" 2 : 173-192, 1993

54 Simes RJ, "Confronting publication bias: a cohort design for meta-analysis" 6 : 11-29, 1987

55 Higgins JPT, "Cochrane Handbook for Systematic Reviews of Interventions. version 5.0.0. The Cochrane Collaboration"

56 "Cochrane Collaboration Individual Patient Data Meta -analysis Methods Group"

57 Egger M, "Bias in meta-analysis detected by a simple, graphical test" 315 : 629-634, 1997

58 Egger M, "Bias in location and selection of studies" 316 : 61-66, 1998

59 Smart CR, "Benefit of mammography screening in women ages 40 to 49 years: current evidence from randomized controlled trials" 75 : 1619-1626, 1995

60 Moher D, "Assessing the quality of reports of randomised trials: implications for the conduct of meta-analyses" 3 : 1-98, 1999

61 Moher D, "Assessing the quality of randomized controlled trials: an annotated bibliography of scales and checklists" 16 : 62-73, 1995

62 Goldfine AB, "Assessing the cardiovascular safety of diabetes therapies" 359 : 1092-1095, 2008

63 Fleiss JL, "Analysis of data from multiclinic trials" 7 : 267-275, 1986

64 Lasagna L, "A study on the placebo response" 16 : 770-779, 1954

65 Galbraith RF, "A note on the graphical presentation of estimated odds ratio from several clinical trials" 7 : 889-894, 1988

66 Chalmers TC, "A method for assessing the quality of a randomized control trial" 2 : 31-49, 1981

67 Oxman AD, "A consumer’s guide to subgroup analyses" 116 : 78-84, 1992

68 Cochrane AL, "1931-1971: A critical review, with particular reference to the medical profession. In: Medicines for the year 2000" Office of Health Economics 1-11, 1979